Company intelligence / Profile preview

Dermalux

Warrington, Cheshire/Warrington area, United Kingdomdermaluxled.com ↗

Ownership: Private
Development stage: Commercial

Overview

Dermalux’s LED phototherapy systems have demonstrated clinically proven results in independent testing and professional case studies. The devices deliver blue, red, and near-infrared light to energize skin cells for regeneration and repair. They are reported to accelerate wound healing, reduce inflammation in conditions like acne and rosacea, improve signs of aging, treat pigmentation issues, and provide pain relief—all with high patient satisfaction rates. The Flex MD system is described as at least three times more powerful than other portable LED devices on the market.

Therapeutic areas: OtherDermatologyNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

International distribution partners in over 40 countries

Beyond the preview

Go deeper on Dermalux.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dermalux.

Explore the full profile